您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Apratoxin A
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Apratoxin A
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Apratoxin A图片
CAS NO:350791-64-9
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
(-)-Apratoxin A
产品介绍
Apratoxin A 是一种蓝藻代谢物,通过诱导 G1 细胞周期停滞和凋亡级联反应来介导抗增殖活性。Apratoxin A 与 Hsp70/Hsc70 结合以促进 Hsp90 客户蛋白的降解。Apratoxin A 可以特异性结合 Sec61 复合体。
生物活性

Apratoxin A, a cyanobacterial metabolite, mediates antiproliferative activity through the induction of G1 cell cycle arrest and anapoptoticcascade. Apratoxin A associates withHsp70/Hsc70to promote the degradation ofHsp90client proteins. Apratoxin A can specifically bind the Sec61 complex[1][2][3].

IC50& Target[2][3]

HSP70

 

HSP90

 

体外研究
(In Vitro)

Apratoxin A (5, 50 nM; 24, 48 小时) 诱导 G1 细胞周期停滞和细胞凋亡。Apratoxin A 在酵母细胞中没有表现出任何生长抑制活性[1]
Apratoxin A (50 nM; 1-24 小时) 抑制 STAT3 的 Tyr705 磷酸化[1]

Cell Cycle Analysis[1]

Cell Line:U2OS cells
Concentration:5, 50 nM
Incubation Time:24, 48 h
Result:Resulted in an accumulation of cells harboring 2N (diploid) content of chromo-somes , suggesting G1-phase cell cycle arrest.
Showed a complete block in cell cycle progression with 5 nM for 48 h.

Apoptosis Analysis[1]

Cell Line:U2OS cells
Concentration:50 nM
Incubation Time:0-48 h
Result:A sub-G1 population emerged 50 nM, suggesting cellular apoptosis.
Had 20-fold higher caspase-3 activity after 48 h.

Western Blot Analysis[1]

Cell Line:U2OS cells
Concentration:50 nM
Incubation Time:1, 4, 12, 24 h
Result:had no effect on phosphorylation of Ser727 , but strongly inhibited constitutive phosphorylation at Tyr705 of STAT3.
体内研究
(In Vivo)

Apratoxin A (0.5-1 mg/kg; 静脉给药; 每 7 天一次; BxPC-3 T1 模型 2 次; A549 模型 3 次) 具有剂量依赖性抗癌活性[2]
Apratoxin A (1 mg/kg; 静脉注射) 具有高分布容积 (Vss=19.31 L/kg) 和中等半衰期 (11.57 小时)[2]

Animal Model:6-week old female NCr nu/nu mice with BxPC-3 T1 or A549 cells[1]
Dosage:0.5, 0.75, 1 mg/kg
Administration:IV; every 7 days; for 2 total doses(BxPC-3 T1 study) or 3 doses (A549 study)
Result:For BxPC3 T1 model, both 1 mg/kg and 0.75 mg/kg were found to exceed the MTD with a treated versus vehicle control effect on tumor size (T/C ratio) of 53% and 41%, respectively. It induced severe body weight loss right after first dose in both 1 mg/kg and 0.75 mg/kg.
In the A549 model, 0.6 mg/kg, 0.5 mg/kg, and 0.4 mg/kg showed T/C ratios of 30%, 24%, and 41%, respectively.
Animal Model:Athymic (NCr nu/nu) mice with A549 tumor cells[2]
Dosage:1 mg/kg
Administration:IV
Result:Showed a high volume of distribution (Vss=19.31 L/kg) and moderate half-life (11.57 hours).
分子量

840.12

Formula

C45H69N5O8S

CAS 号

350791-64-9

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.